NK cell therapy cleared for Phase 2 trial in moderate Alzheimer's

The study is enrolling patients at Glendale, California. “We are excited to announce another important clinical milestone in our mission to …

Do you trust this headline?

Based on recent headline ratings, 58% of this readership currently trusts the local media, which has an average score of 79% regionally and is currently trending negative.


Media Trust Score58%